NCT01089322View on ClinicalTrials.gov

Risk Factors Associated to Difficult-to-control Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

December 9, 2005

Primary Completion Date

April 3, 2009

Study Completion Date

May 13, 2009

Conditions
ASTHMA
Interventions
DRUG

inhaled corticosteroid plus LABA plus oral corticosteroid

formoterol plus budesonide 12/400mcg 2times/day and 6/200 mcg as needed and prednisone 40 mcg

Trial Locations (1)

Unknown

University of São Paulo - Heart Institute and Hospital das Clínicas, São Paulo

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

Rafael Stelmach

OTHER

NCT01089322 - Risk Factors Associated to Difficult-to-control Asthma | Biotech Hunter | Biotech Hunter